{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:58:21Z","timestamp":1761541101676},"reference-count":22,"publisher":"Hindawi Limited","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1121,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1111\/j.1365-2710.2012.01373.x","type":"journal-article","created":{"date-parts":[[2012,8,7]],"date-time":"2012-08-07T00:29:07Z","timestamp":1344299347000},"page":"12-15","source":"Crossref","is-referenced-by-count":15,"title":["Influence of non-steroidal anti-inflammatory drugs on antiplatelet effect of aspirin"],"prefix":"10.1155","volume":"38","author":[{"given":"H.","family":"Yokoyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Soeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Kashiwakura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Kawada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Tokuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2012,8,6]]},"reference":[{"key":"10.1111\/j.1365-2710.2012.01373.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.1021\/bi010045s","article-title":"Structural analysis of NSAID binding by prostaglandin H2 synthase: time-dependent and time-independent inhibitors elicit identical enzyme conformations","volume":"40","author":"Selinsky","year":"2001","journal-title":"Biochemistry"},{"key":"10.1111\/j.1365-2710.2012.01373.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0002-9343(98)00091-6","article-title":"Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs","volume":"104","author":"Cryer","year":"1998","journal-title":"Am J Med"},{"key":"10.1111\/j.1365-2710.2012.01373.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa003199","article-title":"Cyclooxygenase inhibitors and the antiplatelet effects of aspirin","volume":"345","author":"Catella-Lawson","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2710.2012.01373.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1742-7843.2006.pto_371.x","article-title":"Is there an interaction between the cardiovascular protective effects of low-dose aspirin and ibuprofen?","volume":"98","author":"MacDonald","year":"2006","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1111\/j.1365-2710.2012.01373.x-BIB5|cit5","unstructured":"Interview form of Bufferin 81 mg tablets 2008"},{"key":"10.1111\/j.1365-2710.2012.01373.x-BIB6|cit6","unstructured":"Interview form of Brufen tablets 2008"},{"key":"10.1111\/j.1365-2710.2012.01373.x-BIB7|cit7","first-page":"1219","article-title":"Study of pharmacokinetics following oral administration of loxoprofen sodium (CS-600) in humans","volume":"2","author":"Hideo","year":"1986","journal-title":"J Clin Ther Med"},{"key":"10.1111\/j.1365-2710.2012.01373.x-BIB8|cit8","first-page":"820","article-title":"Bioavailability of indomethacin tables in men volunteers","volume":"5","author":"Paul","year":"1986","journal-title":"Clin Pharm"},{"key":"10.1111\/j.1365-2710.2012.01373.x-BIB9|cit9","first-page":"475482","article-title":"Tolerability and bioavailability of diclofenac after single administration of Voltaren\u00ae tablet and suppository in healthy volunteers","volume":"5","author":"Yutaka","year":"1988","journal-title":"Japanese J Inflamm"},{"key":"10.1111\/j.1365-2710.2012.01373.x-BIB10|cit10","first-page":"419","article-title":"Phase 1 study of RAK-591 (etodolac)","volume":"3","author":"Kinya","year":"1987","journal-title":"J Clin Ther Med"},{"key":"10.1111\/j.1365-2710.2012.01373.x-BIB11|cit11","first-page":"329","article-title":"Comparative bioavailability of two capsule formulations of mefenamic acid","volume":"35","author":"Rawashdeh","year":"1997","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1111\/j.1365-2710.2012.01373.x-BIB12|cit12","unstructured":"Interview form of Mobic tablets 2009"},{"key":"10.1111\/j.1365-2710.2012.01373.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/(SICI)1099-081X(199605)17:4<355::AID-BDD960>3.0.CO;2-N","article-title":"Dose dependent pharmacokinetics of naproxen in man","volume":"17","author":"Sarfaraz","year":"1996","journal-title":"Biopharm Drug Dispos"},{"key":"10.1111\/j.1365-2710.2012.01373.x-BIB14|cit14","unstructured":"Interview form of Froben tablets 2010"},{"key":"10.1111\/j.1365-2710.2012.01373.x-BIB15|cit15","first-page":"113","article-title":"Inhibitors of cyclooxygenases: mechanisms, selectivity and uses","volume":"57","author":"Botting","year":"2006","journal-title":"J Physiol Pharmacol"},{"key":"10.1111\/j.1365-2710.2012.01373.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/clpt.1986.129","article-title":"The correlation between blood levels of ibuprofen and clinical analgesic response","volume":"40","author":"Eugene","year":"1986","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/j.1365-2710.2012.01373.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/j.1476-5381.2009.00243.x","article-title":"The interaction of ibuprofen and diclofenac with aspirin in healthy volunteers","volume":"157","author":"Schuijt","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1111\/j.1365-2710.2012.01373.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejphar.2008.07.036","article-title":"Influence of combinations of acetylsalicylic acid, acetaminophen, and diclofenac on platelet aggregation","volume":"595","author":"Katja","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/j.1365-2710.2012.01373.x-BIB19|cit19","first-page":"935","article-title":"Effect of flurbiprofen and aspirin on platelet aggregation","volume":"10","author":"Kelly","year":"1991","journal-title":"Clin Pharm"},{"key":"10.1111\/j.1365-2710.2012.01373.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/0091270007310379","article-title":"Effects of ibuprofen on the magnitude and duration of aspirin\u2019s inhibition of platelet aggregation: clinical consequences in stroke prophylaxis","volume":"48","author":"Francis","year":"2008","journal-title":"J Clin Pharmacol"},{"key":"10.1111\/j.1365-2710.2012.01373.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1177\/0091270004266623","article-title":"Meloxicam does not affect the antiplatelet effect of aspirin in healthy male and female volunteers","volume":"44","author":"Joanne","year":"2004","journal-title":"J Clin Pharmacol"},{"key":"10.1111\/j.1365-2710.2012.01373.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.jacc.2005.01.045","article-title":"Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects","volume":"45","author":"Marte","year":"2005","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2710.2012.01373.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2710.2012.01373.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:04:39Z","timestamp":1671818679000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2710.2012.01373.x"}},"subtitle":["Interaction of aspirin with NSAIDs"],"short-title":[],"issued":{"date-parts":[[2012,8,6]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2710.2012.01373.x","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8,6]]}}}